Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06038734 · ClinicalTrials.gov registry record
Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
A clinical trial of Gastroparesis and Delayed Gastric Emptying, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 108
- Enrollment target
- 1
- Study location
NCT06038734: Completed study of Gastroparesis and Delayed Gastric Emptying, sponsored by University of North Carolina, Chapel Hill.
NCT06038734 is a study of Gastroparesis and Delayed Gastric Emptying that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 108 participants, below the 300-participant average among 44 other Gastroparesis trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06038734, a study of Gastroparesis and Delayed Gastric Emptying, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the increased prescription of GLP-1 agonists for both diabetes and obesity management and the implications of the proposed delayed gastric emptying in the setting of an anesthetic, it is critical to determine if patients taking GLP-1 agonists have an increased rate of delayed gastric emptying. The purpose of this prospective gastric ultrasound evaluation of pre-operative patients is to determine the incidence of a full stomach despite a standard pre-operative fasting period.
Primary Outcome
Presence of retained gastric contents, either liquid or solid
Conditions Studied
Interventions
- DIAGNOSTIC_TEST gastric ultrasound
Study Locations (1)
North Carolina
- University of North Carolina Medical Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2024-04-17 |
What the finished NCT06038734 record still lists
NCT06038734 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 300-participant average among 44 other Gastroparesis trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which gastric ultrasound is the first listed.
NCT06038734 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06038734 about?
NCT06038734 is a clinical study titled "Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.". Given the increased prescription of GLP-1 agonists for both diabetes and obesity management and the implications of the proposed delayed gastric emptying in the setting of an anesthetic, it is critical to determine if patients taking GLP-1 agonists have an increased rate of delayed gastric emptying....
What is the current status of trial NCT06038734?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2023-11-10. Estimated completion is 2024-04-17.
What conditions does trial NCT06038734 study?
This clinical trial studies the following conditions: Gastroparesis, Delayed Gastric Emptying.
What interventions are being tested in trial NCT06038734?
The interventions under investigation include: gastric ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06038734?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06038734 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06038734's enrollment target sits among peer trials
108 18th of 44 higher than 27 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI